115.55
Overview
News
Price History
Option Chain
Financials
Why A Down?
Discussions
Forecast
Stock Split
Dividend History
Agilent Technologies Inc stock is traded at $115.55, with a volume of 1.45M.
It is up +0.99% in the last 24 hours and up +1.18% over the past month.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
See More
Previous Close:
$114.42
Open:
$114.57
24h Volume:
1.45M
Relative Volume:
0.67
Market Cap:
$32.65B
Revenue:
$7.07B
Net Income/Loss:
$1.29B
P/E Ratio:
25.48
EPS:
4.5355
Net Cash Flow:
$993.00M
1W Performance:
-5.19%
1M Performance:
+1.18%
6M Performance:
-21.94%
1Y Performance:
+7.97%
Agilent Technologies Inc Stock (A) Company Profile
Name
Agilent Technologies Inc
Sector
Industry
Phone
(408) 345-8886
Address
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
A
Agilent Technologies Inc
|
115.55 | 32.65B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
TMO
Thermo Fisher Scientific Inc
|
469.71 | 174.55B | 45.20B | 6.88B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
177.25 | 125.45B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
565.93 | 44.95B | 4.30B | 1.06B | 1.04B | 13.08 |
|
WAT
Waters Corp
|
309.87 | 30.42B | 3.17B | 642.63M | 516.49M | 10.77 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Initiated | HSBC Securities | Buy |
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-15-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-02-25 | Initiated | Morgan Stanley | Overweight |
| Oct-08-25 | Initiated | Rothschild & Co Redburn | Buy |
| Oct-08-25 | Upgrade | UBS | Neutral → Buy |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-27-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-17-23 | Downgrade | UBS | Buy → Neutral |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| May-24-23 | Reiterated | Barclays | Equal Weight |
| May-24-23 | Reiterated | BofA Securities | Buy |
| May-24-23 | Reiterated | Citigroup | Neutral |
| May-24-23 | Reiterated | Credit Suisse | Outperform |
| May-24-23 | Reiterated | Evercore ISI | Outperform |
| May-24-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-24-23 | Reiterated | Robert W. Baird | Outperform |
| May-24-23 | Reiterated | SVB Securities | Outperform |
| May-24-23 | Reiterated | Stifel | Hold |
| May-24-23 | Reiterated | TD Cowen | Outperform |
| May-24-23 | Reiterated | Wells Fargo | Overweight |
| May-11-23 | Initiated | Barclays | Equal Weight |
| Jan-10-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jul-08-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-22 | Reiterated | BofA Securities | Buy |
| Feb-23-22 | Reiterated | Citigroup | Buy |
| Feb-23-22 | Reiterated | Cowen | Outperform |
| Feb-23-22 | Reiterated | Evercore ISI | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-23-22 | Reiterated | Wells Fargo | Overweight |
| Nov-23-21 | Reiterated | BofA Securities | Buy |
| Nov-23-21 | Reiterated | Cowen | Outperform |
| Nov-23-21 | Reiterated | Stifel | Hold |
| Mar-18-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Upgrade | UBS | Neutral → Buy |
| Nov-17-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-30-20 | Initiated | Atlantic Equities | Neutral |
| Aug-19-20 | Reiterated | BofA Securities | Neutral |
| Aug-19-20 | Reiterated | Citigroup | Neutral |
| Aug-19-20 | Reiterated | Jefferies | Buy |
| Aug-19-20 | Reiterated | Robert W. Baird | Outperform |
| Aug-19-20 | Reiterated | SVB Leerink | Outperform |
| Aug-19-20 | Reiterated | Stifel | Hold |
| Aug-19-20 | Reiterated | Wells Fargo | Overweight |
| Feb-24-20 | Downgrade | Needham | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Nov-26-19 | Reiterated | Needham | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | UBS | Buy → Neutral |
| Jul-16-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jul-15-19 | Downgrade | Barclays | Overweight → Equal Weight |
View All
Agilent Technologies Inc Stock (A) Latest News
Here's what to expect from Agilent Technologies’ next earnings report - MSN
Agilent Technologies declares $0.255 dividend - MSN
Agilent opens new biopharma centre in Hyd - MSN
Agilent Technologies Inc. stock (US00846U1016): Why its life sciences leadership matters more now fo - AD HOC NEWS
Agilent Technologies Inc. stock (US00846U1016): Why Google Discover changes matter more now - AD HOC NEWS
Is Agilent Technologies stock underperforming the S&P 500? - MSN
Agilent Technologies, Inc. $A is Impax Asset Management Group plc's 6th Largest Position - MarketBeat
Agilent doubling headcount in India - The Economic Times
Here's What to Expect From Agilent Technologies’ Next Earnings Report - Barchart.com
Agilent Technologies Inc (NYSE:A): A Quality Investing Candidate with Strong Profitability and Cash Flow - ChartMill
Does Agilent (A) Settling Axion Dispute Clarify Its Push Into Cloud Lab Data Recurring Revenues? - simplywall.st
Agilent Technologies Inc (A) Shares Fall 5.0% -- What GF Score o - GuruFocus
Agilent Technologies Inc. stock outperforms competitors despite losses on the day - MarketWatch
Earnings snapshot: Agilent Technologies misses FQ1 estimates; gives FQ2 and raises FY26 outlook, above forecast - MSN
Agilent to acquire Biocare Medical for $950M, expanding pathology portfolio - MSN
Universal Beteiligungs und Servicegesellschaft mbH Sells 54,276 Shares of Agilent Technologies, Inc. $A - MarketBeat
Boston Trust Walden Corp Sells 21,880 Shares of Agilent Technologies, Inc. $A - MarketBeat
Is Agilent Technologies a Better Buy Than Danaher? - Trefis
Agilent appoints Rodney Gonsalves as interim CFO following McMahon’s departure - MSN
Global Cloud ELN Service Market | USA, China, India Lead | Thermo Fisher Scientific, Agilent Technologies, Dassault Systèmes Drive Digital Lab Transformation - The AI Journal
TRADE NEWS: Agilent Technologies Introduces HaloPlex Next-Generation Sequencing Panels Targeting Can - Yahoo
Agilent’s Expanding Role in Advanced Therapeutics - Contract Pharma
Agilent Technologies (A) Launches Key Cancer Diagnostic Tool - GuruFocus
Agilent Technologies, Inc. $A Shares Purchased by Zurcher Kantonalbank Zurich Cantonalbank - MarketBeat
Agilent Technologies, Inc. $A Shares Sold by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat
Agilent Technologies Inc. stock (US00846U1016): Is life sciences strength enough to drive steady gai - AD HOC NEWS
Axion Biosystems and Agilent Technologies Res - Moomoo
Axion Biosystems And Agilent Technologies Resolve Litigation - TradingView
Agilent bets on pathology innovation with Biocare acquisition - MSN
Axion BioSystems and Agilent Technologies Resolve Litigation - Business Wire
Mirae Asset Global Investments Co. Ltd. Grows Holdings in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies Inc stock (US00846U1016): Why Google Discover changes matter more now - AD HOC NEWS
Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 31.85% Potential Upside for Investors - DirectorsTalk Interviews
Chromatograph (Labor): Precision Tools Drive Agilent's Lab Market Edge - AD HOC NEWS
Agilent Cancer Research Push Spurs Collaboration Focus And Investor Reassessment - Yahoo Finance
Chromatograph (Labor): Advances in Tech Boost Agilent's Lab Market Edge - AD HOC NEWS
11,390 Shares in Agilent Technologies, Inc. $A Acquired by Lecap Asset Management Ltd. - MarketBeat
KBC Group NV Has $11.17 Million Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
Agilent Stock Performance & Valuation Analysis 2026 | Business ReviewNews and Statistics - IndexBox
Is Agilent’s Oncology Push and Oxford Nanopore Tie-Up Quietly Reframing Its Investment Narrative (A)? - Sahm
Agilent Technologies Inc (A) Stock Up 3.1% and Still Undervalued -- GF Score: 93/100 - GuruFocus
Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch
Agilent Technologies, Inc. $A Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Q4 2025 Earnings Call Transcript - MSN
Agilent Technologies Inc stock (US00846U1016): Why its life sciences leadership matters more now for - AD HOC NEWS
Agilent (A) Showcases Innovations at AACR 2026 Annual Meeting - GuruFocus
Agilent Ekes Higher Ahead of Cancer Research Conference - Baystreet.ca
Agilent Showcases Cancer Research Solutions at AACR 2026 - PharmiWeb.com
Sumitomo Mitsui Trust Group Inc. Trims Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies Inc Stock (A) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):